explore -WSS

explore

author：knowledge 2025-09-07 06:53:52 - browse：4

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： How AI can help patients find reliable information about doctors

WSS

Results on Novartis prostate cancer therapy could expand its use

STAT Summit: Meghan O’Rourke on making chronic illness visible

The 10 drugs up first for Medicare price negotiation

Health tech investors get more selective as pandemic boom fades

How to fix cancer clinical trials' diversity problem

STAT Readout: Friday, Oct. 20 biotech updates

focus

explore

leisure time

Moonlake's readout produced a cash windfall. Risks remain

UnitedHealth, Optum discontinue NaviHealth name

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

STAT Summit: Meghan O’Rourke on making chronic illness visible

Jerome Adams on the need for new antivirals for Covid

Amazon on where the company's health care bets are headed next

Supreme Court strikes down use of affirmative action

NIH nominee Bertagnolli will get October confirmation hearing

Dobbs anniversary: the lost opportunity of abortion as health care

STAT Summit: Ending the crisis of Black deaths in the U.S.

Wikipedia

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

What drug price negotiations mean for Medicare Part D

The (many) problems with a new study criticizing cancer screening

A new House health package & hospitals’ new site

CZI to create biohub to build anti

Illumina names Agilent executive as new CEO

entertainment

hotspot

focus

leisure time